may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.pm
.
.
.
``much of this delay in implementation can be attributed to the lack of coordination and cooperation between the city and county.''
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.